Skip Navigation


European Heart Journal Advance Access originally published online on November 22, 2006
European Heart Journal 2006 27(24):3073; doi:10.1093/eurheartj/ehl383
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/24/3073    most recent
ehl383v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Elliott, P.
Right arrow Articles by McKenna, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, P.
Right arrow Articles by McKenna, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy

Perry Elliott

Cardiology Department
The Heart Hospital
16–18 Westmoreland Street
London W1G 8PH
UK
Tel: +44-207 573 8888
Fax: +44-207 573 8838
E-mail address: pelliott@doctors.org.uk

Juan Gimeno

Servicio de Cardiologia
Hospital Virgen de la Arrixaca
Murcia
Spain

Maite Tomé

Cardiology Department
The Heart Hospital
London
UK

William McKenna

Cardiology Department
The Heart Hospital
London
UK

The first 10% of the full text of this article appears below.

We thank Maron et al. for their editorial on our paper.1,2

Hypertrophic cardiomyopathy (HCM) is a capricious disorder, characterized by heterogeneity at all levels. Together with its relative rarity, this has resulted in a dearth of evidence-based practice. The authors suggest that cardiologists rely on guidance from a few major centres . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
R. A. Nishimura and S. R. Ommen
Hypertrophic Cardiomyopathy, Sudden Death, and Implantable Cardiac Defibrillators: How Low the Bar?
JAMA, July 25, 2007; 298(4): 452 - 454.
[Full Text] [PDF]